Connection

Elizabeth Hill to Lung Neoplasms

Back to Details
This is a "connection" page, showing publications Elizabeth Hill has written about Lung Neoplasms.
Elizabeth Hill
Connection Strength
0.140
Lung Neoplasms
  1. ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Lancet Oncol. 2018 05; 19(5):694-704.
    View in: PubMed
    Score: 0.082
  2. Plasma sphingolipids and lung cancer: a population-based, nested case-control study. Cancer Epidemiol Biomarkers Prev. 2013 Aug; 22(8):1374-82.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.